Skip to content
lifestyle.ubi-interactive.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Belhaven Biopharma
Belhaven Biopharma Initiates Pivotal Study of BBP01, a Nasal Powder Formulation of Epinephrine to Treat Anaphylaxis
October 6, 2026
Belhaven Announces Significant Expansion of Nasdepi Patent Portfolio, Commercial Supply Readiness, and FDA Alignment on Key Topics
July 16, 2026